{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "Organization",
      "@id": "https://www.diapin.com/#organization",
      "name": "About Us",
      "url": "https://www.diapin.com/",
      "description": "--> About Us | Diapin Therapeutics top of page About Us Our Team Science Pipeline Publications Resources Product Candidates DT-109 DT-678 Disease Focus Arterial Thrombosis Myocardial Infarction Stroke MASH Primary Biliary Cholangitis Familial Partial Lipodystrophy Type II Diabetes News Contact Us Investors & Collaborations Novel Therapies for Cardiovascular and Metabolic Diseases Diapin is a clinical-stage drug development company developing novel therapeutics for the treatment of stroke, myocardial infarction, MASH, primary biliary cholangitis, familial partial lipodystrophy, and Type 2 diabetes. Our product candidates About Diapin Therapeutics ​ Diapin was founded by Dr. Yuqing (Eugene) Ch"
    },
    {
      "@type": "WebPage",
      "@id": "https://directory.websdocs.com/business/about-us-cf36c5cf36#asg",
      "name": "About Us ASG Directory Profile",
      "url": "https://directory.websdocs.com/business/about-us-cf36c5cf36",
      "isPartOf": {
        "@id": "https://www.diapin.com/#organization"
      },
      "description": "Public business information published by the WebsDocs ASG Directory."
    }
  ]
}